Losartan potassium

Key facts

Active substance
Losartan potassium
Therapeutic area
Cardiovascular diseases
Decision number
P/9/2008
PIP number
Losartan potassium
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral liquid dosage form
Condition(s) / indication(s)
  • Proteinuria
  • Treatment of heart failure
  • Treatment of hypertension
Route(s) of administration
Oral route
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.

Tel. +33 180464738
E-mail: pip.information@merck.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-000008-PIP01-07
Compliance opinion date
06/02/2009
Compliance outcome
positive

Decision

Topics

How useful was this page?

Add your rating